Himax (HIMX) Q3 2026 Earnings Call Transcript

Himax reported Q3 2026 revenue of $246.8 million, up 8.5% sequentially and in line with guidance, while diluted EPS of $0.107 exceeded its $0.080–$0.100 outlook; net profit rose to $18.6 million from $1.1 million a year earlier. Management forecast Q4 revenue down 22%–26% sequentially and EPS of $0.045–$0.065 per diluted ADS, citing a sharp correction in automotive driver IC orders tied partly to Chinese export and inventory uncertainty. It expects 2026 automotive IC revenue to grow about 10% and sees potential double-digit company revenue growth in 2027, while warning that supplier price increases pose gross-margin challenges.

Analysis

HIMX | Inventory reset first, mix transition later. The near-term issue is not simply weaker auto demand: panel customers appear to have converted unusually strong prior orders into excess channel and in-transit inventory. That makes a quick rebound less reliable than the company’s full-year growth narrative implies; order normalization, rather than vehicle production, is the key 1–3 month signal. Rising receivables and inventory alongside 93-day DSO add a working-capital check, though they do not by themselves establish a collection problem.

Over 6–18 months, higher non-driver content could reduce dependence on more cyclical display-driver orders. But the margin benefit is not assured: 2027 foundry and backend price increases may arrive before customer price recovery, while capacity reservations support delivery reliability more directly than pricing power. FOCI’s planned investment is encouraging for the CPO ecosystem, but is not HIMX revenue or proof of customer qualification; yield, validation, and ramp timing remain the gating items. Alibaba’s WiseEye adoption validates a design-in, not meaningful near-term economics absent unit volumes and product-level revenue disclosure.

The asymmetry is a sharp guided downturn against an unquantified 2027 recovery. The potential divestiture gain should be treated as non-recurring, not as evidence of operating earnings power. A sustained recovery in auto orders or disclosed CPO production volumes would challenge the cautious near-term view; further customer cuts or margin pressure would strengthen it.

Key Decisions for Investors

• Do not chase HIMX on the 2027 pipeline narrative. For a tactical bearish expression, consider a defined-risk 1–3 month put spread only after a relief rally fails and if implied volatility makes the spread economical; avoid an outright short without price and borrow context. Thesis weakens if the next update shows automotive orders stabilizing and gross margin holding despite supplier increases.
• Track the next two quarterly updates for panel-maker order revisions, inventory, DSO, and evidence of supplier-cost pass-through. A renewed rise in DSO or inventory without sales recovery would increase downside risk; stabilization in these measures alongside improving auto orders would argue to cover bearish exposure.
• Treat WiseEye and CPO as watch-list catalysts, not base-case earnings support. Seek disclosed production timing, customer qualification/yield progress, and revenue contribution; do not infer HIMX economics from Alibaba’s product adoption or FOCI’s capital spending alone.